LOADING
Comparing Exxon Mobil Corporation (XOM) and Merck & Company (MRK) across the Energy and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | XOM | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $634.3B | $307.2B |
| P/E Ratio | 26.2 | 36.0 |
| Forward P/E | 14.1 | 48.3 |
| PEG Ratio | 1.32 | 12.06 |
| EPS | $5.94 | $3.55 |
| Revenue Growth (YoY) | 44.1% | 4.9% |
| Profit Margin | 9.1% | 13.6% |
| Return on Equity | 12.6% | 18.9% |
| Dividend Yield | 2.60% | 2.52% |
| Beta | 0.16 | 0.21 |
| 52-Week High | $175.22 | $135.05 |
| 52-Week Low | $102.27 | $75.81 |
| Volume | -- | -- |
Exxon Mobil Corporation is the larger company by market capitalization. Exxon Mobil Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Exxon Mobil Corporation offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.